International Clinical Trial: Aspirin for Stroke Prevention After Endovascular Aortic Arch Repair: A Multicenter, Double-Blind, Randomized Controlled Trial

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205250) titled 'Aspirin for Stroke Prevention After Endovascular Aortic Arch Repair: A Multicenter, Double-Blind, Randomized Controlled Trial' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Care Provider, Outcomes Assessor).

Primary Sponsor: Wei Wu

Condition: Type B or Non-A Non-B Aortic Dissection Thoracic Aortic Aneurysm

Intervention: Drug: enteric-coated aspirin tablets (100 mg once daily, Bayer Healthcare, specification: 100 mg/tablet)

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of Firs...